Latest News

New target for chronic pain treatment found

The enzyme PIP5K1C controls the activity of cellular receptors that signal pain, researchers have found. By reducing the enzyme, researchers showed that levels of a lipid called PIP2 is also lessened. They also found a compound that can dampen the activity of PIP5K1C. These findings could lead to a new kind of pain reliever for the more than 100 million people who suffer from chronic pain in the US.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Analysis of spider venom reveals seven promising compounds with potential to relieve chronic pain

  • Neuroscientists identify new way several brain areas communicate

  • Air pollution linked to slower cognitive development in children

  • Creative genius driven by distraction

  • Republicans trust science -- except when it comes to health insurance and gay adoption

  • Alcohol screening, intervention for risky drinking: A guide for physicians

  • Anxious people more apt to make bad decisions amid uncertainty

  • Myelin-maker: How an FDA-approved drug boosts myelin synthesis

  • Vaccine skeptics aren't swayed by emotional scare tactics

  • Administering Sedatives for Patients Receiving General Anesthesia Questioned

  •